Key result
Tailored optimization of individual LV wall motion in CRT non-responders improved LVEF from 27% to 39% and functional class at 3 months.
Why the study?
Does tailored optimization of LV wall motion improve clinical and echocardiographic outcomes in CRT non-responders with a discordant LV lead?
Does tailored optimization of LV wall motion improve clinical and echocardiographic outcomes in CRT non-responders with a discordant LV lead?
Tailored optimization of LV wall motion using integrated imaging can significantly improve clinical and echocardiographic outcomes in CRT non-responders with discordant LV leads.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for tailored LV optimization in CRT non-responders; prospective trials needed before clinical adoption.
AIMS: A discordant left ventricular (LV) lead position can be responsible for cardiac resynchronization therapy (CRT) non-response. In this study, tailored optimization of the individual LV wall motion was evaluated for the outcome in these patients. METHODS AND RESULTS: Two hundred and forty-six CRT outpatients were screened for non-response due to a discordant LV lead. In 17 patients, three-dimensional data of fluoroscopic rotation scan and echocardiography were integrated to analyse the individual LV wall motion with respect to the LV lead position. Optimization was guided by the systolic dyssynchrony index (SDI) and LV ejection fraction (LVEF) during different interventricular (VV)-delay programming. If re-programming failed, implantation of a second LV lead was performed. A discordant or partly concordant LV lead position was found in nearly all patients (16/17, 94%), which contributed to an unchanged baseline amount of LV dyssynchrony with either CRT on or off (SDI 11.3 vs. 11.0%; P = 0.744). In the majority of patients, VV-delay re-programming achieved better resynchronization, 4/17 patients needed implantation of a second LV lead. After 3 months, significant improvement of NYHA functional class (1 class; P = 0.004), peak oxygen consumption (10 vs. 13 mL/min/kg; P = 0.008), LVEF (27 vs. 39%; P = 0.003), and SDI (11.0 vs. 5.8; P = 0.02) was observed. Clinical and echocardiographic responses were found in 77 and 59%, respectively, with even good results on long-term follow-up. CONCLUSION: Tailored optimization of the individual LV wall motion can lead to significant clinical and echocardiographic improvements in previous CRT non-responders with a discordant LV lead position.
No takes yet. Share an insight, caveat, or question.
Nitsche et al. (2015) studied Cardiac resynchronization therapy (CRT) non-response (n=17). Tailored optimization of individual LV wall motion (VV-delay re-programming or second LV lead implantation) vs. Baseline (pre-optimization) was evaluated on Left ventricular ejection fraction (LVEF) (p=0.003). Tailored optimization of individual LV wall motion in CRT non-responders improved LVEF from 27% to 39% and functional class at 3 months.
Synapse has enriched 10 related papers. Consider them for comparative context: